CPI-1714

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameCPI-1714
Drug Alias NameNRT-115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase inhibitorsFree radicals scavengers
TargetsMitogen-activated protein kinaseFree radicals
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRenovis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRenovis
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A